Nancy A Risebrough (Nancy Risebrough)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Chronic Obstructive Pulmonary Disease

Prognostic Factors

Top Venues

International journal of chronic obstructive pulmonary disease

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Afisi S Ismaila, Katrin Haeussler, Alexandrosz Czira, Ji-Hee Youn, Mia Malmenas, Nancy A Risebrough, Jatin Agarwal, Maria Nassim, Raj Sharma, Chris Compton, Claus F Vogelmeier, Meilan K Han, David M G Halpin
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in therapy 39 (9) (2022)
Victoria Federico Paly, Ian P Naya, Necdet B Gunsoy, Maurice T Driessen, Nancy A Risebrough, Andrew Briggs, Afisi S Ismaila
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study. International journal of chronic obstructive pulmonary disease 14 (2019)